Contrast-enhanced intravascular ultrasound: Combining morphology with activity-based assessment of plaque vulnerability

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 5, 2007, Pages 917-925

  Vavuranakis, Manolis ^a   Kakadiaris, Ioannis A ^b   Papaioannou, Theodoros G ^c   O'Malley, Sean M ^b   Carlier, Stephane ^d   Naghavi, Morteza ^e   Stefanadis, Christodoulos ^c  

^a Department of Computer Science ^*  (Greece)

^b University of Houston   (United States)

^c UNIVERSITY OF ATHENS   (Greece)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^e Association for Eradication of Heart Attack   (United States)

Author keywords

ACES ; Contrast enhanced intravascular ultrasound; Harmonic IVUS; Image analysis; Microbubbles; Neovascularization; Vasa vasorum

Indexed keywords

AF 0150; AI 700; ALBUNEX; CARDIOSPHERE; CONTRAST MEDIUM; ECHO CONTRAST MEDIUM; FS 069; LENOVIST; LUMINITY; NC 100100; PERFLEXANE; PERFLUTREN; QUANTISON; SHU 508; SONAVIST; SONOGEN; SONOVUE; UNCLASSIFIED DRUG;

ATHEROSCLEROTIC PLAQUE; BLOOD FLOW; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; DRUG INDICATION; DRUG RETENTION; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; INTRACORONARY INFUSION; INTRAVASCULAR ULTRASOUND; MICROBUBBLE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; REVIEW; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; ULTRASOUND SCANNER; VASA VASORUM;

ACUTE CORONARY SYNDROME; ANIMALS; CONTRAST MEDIA; CORONARY ARTERY DISEASE; EQUIPMENT DESIGN; HUMANS; IMAGE ENHANCEMENT; ULTRASONOGRAPHY, INTERVENTIONAL; VASA VASORUM;

EID: 34848920822     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.5.917     Document Type: Review

References (46)

1. Naghavi M, Libby P, Falk E et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation 108, 1664-1672 (2003).
2. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N. Engl. J. Med. 336, 1276-1282 (1997).
3. Constantinides P. Cause of thrombosis in human atherosclerotic arteries. Am. J. Cardiol. 66, 37G-40G (1990).
4. Kolodgie FD, Burke AP, Farb A et al. The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr. Opin. Cardiol. 16, 285-292 (2001).
5. Virmani R, Kolodgie FD, Burke AP et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler. Thromb. Vasc. Biol. 25, 2054-2061 (2005).
6. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 20, 1262-1275 (2000).
7. Pregowski J, Tyczynski P, Mintz GS et al. Intravascular ultrasound assessment of the spatial distribution of ruptured coronary plaques in the left anterior descending coronary artery. Am. Heart J. 151, 898-901 (2006).
8. Hong MK, Mintz GS, Lee CW et al. The site of plaque rupture in native coronary arteries: a three-vessel intravascular ultrasound analysis. J. Am. Coll. Cardiol. 46, 261-265 (2005).
9. Vavuranakis M, Papaioannou TG, Stefanadis C. In the search of the vulnerable plaque: current diagnostic techniques and future directions. Vasc. Dis. Prev. 4, 21-29 (2007).
10. Nair A, Kuban BD, Tuzcu EM, Schoenhagen P, Nissen SE, Vince DG. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106, 2200-2206 (2002).
11. de Korte CL, Cespedes EI, van der Steen AF, Pasterkamp G, Bom N. Intravascular ultrasound elastography: assessment and imaging of elastic properties of diseased arteries and vulnerable plaque. Eur. J. Ultrasound 7, 219-224 (1998).
12. de Korte CL, Sierevogel MJ, Mastik F et al. Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study. Circulation 105, 1627-1630 (2002).
13. de Korte CL, van der Steen AF. Intravascular ultrasound elastography: an overview. Ultrasonics 40, 859-865 (2002).
14. Baldewsing RA, Mastik F, Schaar JA, Serruys PW, van der Steen AF. Young's modulus reconstruction of vulnerable atherosclerotic plaque components using deformable curves. Ultrasound Med. Biol. 32, 201-210 (2006).
15. Shi Y, Witte RS, O'Donnell M. Identification of vulnerable atherosclerotic plaque using IVUS-based thermal strain imaging. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 52, 844-850 (2005).
16. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat. Rev. Drug Discov. 3, 527-532 (2004).
17. McCulloch M, Gresser C, Moos S et al. Ultrasound contrast physics: a series on contrast echocardiography, article 3. J. Am. Soc. Echocardiogr. 13, 959-967 (2000).
18. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin. Radiol. 51(Suppl. 1), 50-55 (1996).
19. Tel C, Sakamaki T, Shah PM et al. Myocardial contrast echocardiography: a reproducible technique of myocardial opacification for identifying regional perfusion deficits. Circulation 67, 585-593 (1983).
20. Colonna P, Cadeddu C, Chen L, Iliceto S. Clinical applications of contrast echocardiography. Am. Heart J. 141, S36-S44 (2001).
21. Iwakura K, Ito H, Nishikawa N et al. Use of echocardiography for predicting myocardial viability in patients with reperfused anterior wall myocardial infarction. Am. J. Cardiol. 85, 744-748 (2000).
22. Hirooka K, Yamagishi M, Miyatake K. Images in cardiology. Visualisation of ablated septal myocardium using myocardial contrast echocardiography in hypertrophic obstructive cardiomyopathy. Heart 84, 382 (2000).
23. Feinstein SB. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am. J. Physiol. Heart Circ. Physiol. 287, H450-H457 (2004).
24. Kono Y, Pinnell SP, Sirlin CB et al. Carotid arteries: contrast-enhanced US angiograpby-preliminary clinical experience. Radiology 230, 561-568 (2004).
25. Yuan C, Kerwin WS, Ferguson MS et al. Contrast-enhanced high resolution, MRI for atherosclerotic carotid artery tissue characterization. J. Magn. Reson. Imaging 15, 62-67 (2002).
26. Moreno PR, Purushothaman KR, Fuster V O'Connor WN. Intimomedial interface damage and adventitial inflammation is increased beneath disrupted atherosclerosis in the aorta: implications for plaque vulnerability. Circulation 105, 2504-2511 (2002).
27. Moulton KS, Vakili K, Zurakowiski D et al. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. USA. 100(8), 4736-4741 (2003).
28. Fleiner M, Kummer M, Mirlacher et al. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation 110, 2843-2850 (2004).
29. Moreno PR, Purushothaman KR, Fuster V et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 110, 2032-2038 (2004).
30. Barger AC, Beeuwkes R, Lainey LL, Silverman KJ. Hypothesis: vasa vasorum and neovascularization of human coronary arteries - a possible role in the pathophysiology of atherosclerosis. N. Engl. J. Med. 310, 175-177 (1984).
31. Kolodgie FD, Gold HK, Burke AP et al. Intraplaque hemorrhage and progression of coronary atheroma. N. Engl. J. Med. 349, 2316-2325 (2003).
32. Jorgensen SM, Demirkaya O, Ritman EL. 3D imaging of vasculature and parenchyma in intact rodent organs with x-ray micro-CT. Am. J. Physiol. 275, H1102-H1114 (1998).
33. Herrmann J, Lerman LO, Rodriguez-Porcel M et al. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc. Res. 51, 762-766 (2001).
34. Gossl M, Rosol M, Malyar NM et al. Functional anatomy and hemodynamic characteristics of vasa vasorum in the walls of porcine coronary arteries. Anat. Rec. A Discov. Mol. Cell. Evol. Biol. 272, 526-537 (2003).
35. Kerwin W, Hooker A, Spilker M et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 107, 851-856 (2003).
36. Goertz DE, Frijlink ME, de Jong N, van der Steen AF. Nonlinear intravascular ultrasound contrast imaging. Ultrasound Med. Biol. 32, 491-502 (2006).
37. Goertz DE, Frijlink ME, Tempel D et al. Contrast harmonic intravascular ultrasound: a feasibility study for vasa-vasorum imaging. Invest. Radiol. 41, 631-638 (2006).
38. van der Steen AF, Baldwsing RA, Degertekin FL et al. IVUS beyond the horizon. Euro Interv. 2, 132-142 (2006).
39. Kakadiaris IA, O'Malley SM, Vavuranakis M et al. Intravascular ultrasound-based imaging of vasa vasorum for the detection of vulnerable atherosclerotic plaque. J. Am. Coll. Cardiol. 47, 264A (2006).
40. O'Malley SM, Vavuranakis M, Naghavi M, Kakadiaris IA. Intravascular ultrasound-based imaging of vasa vasorum for the detection of vulnerable atherosclerotic plaque. Med. Image Comput. Comput. Assist Interv. Int. Conf. 8, 343-351 (2005).
41. Vavuranakis M, Kakadiaris IA, O'Malley SM et al. Detection of luminal-intimal border and coronary wall enhancement in intravascular ultrasound imaging after injection of microbubbles and simultaneous sonication with transthoracic echocardiography. Circulation 112, e1-e2 (2005).
42. Carlier S, Kakadiaris IA, Dib N et al. Vasa vasorum imaging: a new window to the clinical detection of vulnerable atherosclerotic plaques. Curr. Atheroscler. Rep. 7, 164-169 (2005).
43. Li CH, Liao AH, Ho JA, Li PC. Ultrasonic pulse-inversion fundamental imaging with liposome microbubbles at 25-50 MHz. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 52, 65-79 (2005).
44. Vavuranakis M, Papaioannou TG, Kakadiaris IA et al. Detection of perivascular blood flow in-vivo by contrast-enhanced intracoronary ultrasonography and computational image analysis technique. Clin. Exp. Pharmacol. Physiol. (2007) (In Press).
45. Vavuranakis M, Kakadiaris IA, O'Malley SM et al. A new method for assessment of plaque vulnerability based on vasa vasorum imaging, by using contrast enhanced intravascular ultrasound and automated differential image analysis. Int. J. Cardiology (2007) (In Press).
46. Kolodgie FD, Narula J, Yuan C, Burke AP. Finn AV, Virmani R. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J. Am. Coll. Cardiol. 49, 2093-2101 (2007).